Qube Research & Technologies (QRT)
ETTX

Qube Research & Technologies (QRT)’s Entasis Therapeutics Holdings Inc. ETTX Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio ETTX Stock Details ETTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-60,355
Closed -$123K – 2320
2020
Q3 		$123K Buy
+60,355
New +$172K ﹤0.01% 1476

Other funds holding ETTX

PBPIA
Pivotal bioVenture Partners Investment Advisor San Francisco, California $280M AUM 181.4% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return

Qube Research & Technologies (QRT)'s ETTX Position: Q4 2020 in Review

Qube Research & Technologies (QRT) sold out of Entasis Therapeutics Holdings Inc. (ETTX) in Q4 2020, closing a stake of 60,355 shares — an estimated $123K sold.

Qube Research & Technologies (QRT) first reported a position in ETTX in Q3 2020 and held it in 1 quarter. The position peaked at $123K in Q3 2020. 25 funds tracked by Wall St. Rank hold ETTX as of Q4 2020.

  • Qube Research & Technologies (QRT) reported no remaining Entasis Therapeutics Holdings Inc. position as of Q4 2020 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 60,355 Entasis Therapeutics Holdings Inc. shares in Q4 2020, an estimated $123K.
  • Qube Research & Technologies (QRT) first reported a position in Entasis Therapeutics Holdings Inc. in Q3 2020 and held it in 1 quarter.
  • Qube Research & Technologies (QRT)'s Entasis Therapeutics Holdings Inc. position peaked at $123K in Q3 2020.
  • 25 funds tracked by Wall St. Rank held Entasis Therapeutics Holdings Inc. as of Q4 2020.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q4 2020, filed 16 Feb 2021.